tiprankstipranks
Trending News
More News >
Plus Therapeutics (PSTV)
NASDAQ:PSTV
US Market
Advertisement

Plus Therapeutics (PSTV) Financial Statements

Compare
1,454 Followers

Plus Therapeutics Financial Overview

Plus Therapeutics's market cap is currently $53.75M. The company's EPS TTM is $; its P/E ratio is -0.24; Plus Therapeutics is scheduled to report earnings on October 16, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Plus Therapeutics Earnings and Revenue History

Plus Therapeutics Debt to Assets

Plus Therapeutics Cash Flow

Plus Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis